Complaints Outcomes

Search

Search Results

Search Again
Pharmacist Registrant 17 (Jul 24, 2016)

Pharmacist Registrant 17 has satisfied the terms of an agreement reached with the Inquiry Committee dated July 24, 2016. Limits and conditions on pharmacist registrant’s registration as a pharmacist have now been removed. The pharmacist registrant’s name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Buhecha , Nikhil Kantilal (Jul 20, 2016)

The Inquiry Committee received and considered a consent order proposal from Nikhil Kantilal Buhecha (the “Registrant”) prior to the commencement of a hearing into allegations against him, set to proceed before the Discipline Committee on July 18, 2016.  The proposal was made pursuant to section 37.1 of the Health Professions Act.  The Inquiry Committee reviewed the proposal, the allegations against the Registrant set out in the Citation and decided to accept the terms which are now orders pursuant to section 37.1(3)(a) of the Health Professions Act.  The Inquiry Committee considers that the following orders made against the Registrant are consistent with the seriousness of the facts and circumstances set out in the Citation:

  • That the Registrant’s registration as a Full Pharmacist be suspended for a period of three (3) years, to commence on July 20, 2016;
  • That the Registrant pay a $50,000 fine and $100,000 in costs - $75,000 of the total amount to be paid prior to his reinstatement and the remaining $75,000 to be paid no later than one year from date of reinstatement;
  • That the Registrant not be an owner or director of a pharmacy in British Columbia for a period of five (5) years from the date his suspension commences;
  • That prior to reinstatement the Registrant comply with Criminal Records Review Act requirements;
  • That prior to reinstatement the Registrant write a letter to the Inquiry Committee reflecting upon his conduct in this matter and what he has learned; and
  • That prior to reinstatement the Registrant successfully complete Parts 1 and 2 of the Pharmacist Qualifying Exam through the Pharmacy Examining Board of Canada, the College’s Jurisprudence Exam, and the ProBE ethics program.​
Pharmacist Registrant 15 (Jul 15, 2016)

Pharmacist registrant has satisfied the terms of an agreement reached with the Inquiry Committee dated September 18, 2015. Limits and conditions on pharmacist registrant’s registration as a pharmacist have now been removed. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 29 (Jul 1, 2016)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with pharmacist registrant to suspend his registration as a pharmacist effective July 1, 2016. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The registrant's name has been withheld, pursuant to 39.3(4) of the Health Professions Act.

Sands, Ian Colin (Jun 15, 2016)

Ian Colin Sands has satisfied the terms of an agreement reached with the Inquiry Committee dated June 22, 2015.  Limits and conditions on Ian Colin Sands’ registration have now been removed. 

Singh, Amarjit Kaur (May 25, 2016)

Pursuant to s. 35(4) of the Health Professions Act, the Inquiry Committee has determined that the limits and conditions imposed on the practice of pharmacy on Amarjit Kaur Singh are no longer necessary. Limits and conditions on Amarjit Kaur Singh’s registration have now been removed.

Parkins, Janet Carol (May 17, 2016)

Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with registrant Janet Carol Parkins to change her registration status to Former Pharmacist and is no longer a registrant of the College.  

On March 12, 2015, the registrant dispensed allopurinol to a patient which interacted with her existing medication, azathioprine. The drug-drug interaction between allopurinol and azathioprine is serious and well-known.  The two medications were refilled (by other pharmacists) for the next two months until the patient began experiencing symptoms of pancytopenia and was admitted to the hospital.  The patient remained in the hospital for 18 days during which she received multiple blood transfusions and required blood tests to determine the cause of her symptoms.

The Inquiry Committee found that the registrant did not conduct a PharmaNet review and failed to detect the drug-drug interaction on one occasion. The registrant provided basic counselling to the patient at the time of releasing the drug but did not alert the patient of the drug-drug interaction.  The Inquiry Committee determined that in the interest of public safety, a 1-month suspension of the registrant’s licence and educational remediation was appropriate for addressing this incident.  In lieu of suspension and remediation, the registrant requested and reached an agreement with the Inquiry Committee to relinquish her licence. If the registrant applies for reinstatement of her licence in the future, she will be required to complete the remediation steps set out by the Inquiry Committee and will be subject to a practice audit.  

Pharmacy Technician Registrant 1 (Apr 24, 2016)

The Inquiry Committee, pursuant to s. 36 of the Health Professions Act, has reached an agreement with the pharmacy technician registrant to voluntarily suspend the registration as a pharmacy technician effective April 24, 2016. The agreement remains in place until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacy technician’s name has been withheld pursuant to section 39.3(4) of the Health Professions Act.

Pharmacist Registrant 24 (Apr 22, 2016)
(Aug 12, 2016 – Limits and conditions removed)

The Inquiry Committee had previously suspended pharmacist registrant’s registration for an indefinite period on February 12, 2016. Pursuant to Section 36 of the Health Professions Act, the Inquiry Committee reinstated pharmacist registrant’s registration and had reached an agreement on March 16, 2016 in which the Registrant was asked to consent to certain limits and conditions. Those previous limits and conditions have been revised as follows:

  • Return to work on a full-time basis (8 hours/day), on the condition that a medical assessment is completed after 2 weeks with the treating healthcare professional;

  • Remain on medications as prescribed by healthcare professionals and medical providers; and

  • Take only one (1) online course or study in May 2016 so that it is not too stressful.

This agreement remains in effect until April 22, 2021. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act

Pharmacist Registrant 9 (Mar 23, 2016)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached a new agreement with the pharmacist registrant for an additional five year period until March 23, 2021, whereby the registrant consented to undertakings involving regular medical monitoring for fitness to practice pharmacy. The undertakings in the agreement include, but are not limited to the following:

  1. Informing all managers and employers with whom he gains employment of his medical condition and the need to maintain vigilance with respect to recovery and the possibility of relapse, and the limits and conditions on his registration pursuant to the agreement;

  2. Ensuring that all managers and employers with whom he gains employment submits a written statement to the College declaring their awareness of his medical condition and the agreement;

  3. Being restricted from the following roles in his practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor.

     

  4. Notifying the College of:

    1. all changes in his places of employment as a pharmacist
    2. all changes in residential address and phone number; and
    3. all changes in medical providers

The name of the registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.

Pages